US-Czech Conference on Advanced Nanotechnology and Chemistry
17 th – 18th January 2018
US -Czech Conference on Advanced Nanotechnology and Chemistry was held on January 17-18, 2018 in Prague by US Ambassy, Office of Naval Research Global and Palacký University Olomouc, Faculty of Science, Regional Centre of Advanced Technologies and Materials.
More than 30 speakers from USA and Czech were invited, among them also was invited outstanding scientist, professor Yury Gogotsi, founder director of Drexel Nanomaterials Institute in Drexel University, USA. His research group works on nanostructured carbons, 2D carbides and other nanomaterials for energy, water and biomedical applications.
Main goals of the conference were assess each country’s capabilities in nanotechnology and chemistry; Identify technical challenges for exploiting and furthering nanotechnology and chemistry; identify potential projects for US-Czech research collaboration; identify US and Czech funding sources for nanotechnology and chemistry research; kick-off celebration of 100 years of US-Czech diplomatic relations
The year 2018 marks the centennial of the founding of Czechoslovakia and the formal beginning of U.S.-Czech diplomatic relations, and the U.S. Embassy in Prague will proudly celebrate the occasion throughout the year. They will mark 100 years of U.S.-Czech relations by supporting projects focused on the U.S.-Czech friendship and history, and by participating in events around the country that highlight the U.S.-Czech partnership.
Source: www.conference.rcptm.com
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Our team was very delighted to take part in International Symposium "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene event in Europe this year! 
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.